Drug
norethisterone acetate
norethisterone acetate is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
2
40%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
completed240%
unknown360%
Recent Activity
0 active trials
Showing 5 of 5
unknownphase_4
A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts
NCT05293574
unknown
Management of Uterine Leiomyomata and Adenomyosis
NCT05153928
unknownphase_3
Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .
NCT04290013
completedphase_2
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
NCT01160315
completedphase_2
Genistein and Endometrial Hyperplasia
NCT00453960
Clinical Trials (5)
Showing 5 of 5 trials
NCT05293574Phase 4
A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts
NCT05153928
Management of Uterine Leiomyomata and Adenomyosis
NCT04290013Phase 3
Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .
NCT01160315Phase 2
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
NCT00453960Phase 2
Genistein and Endometrial Hyperplasia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5